505 related articles for article (PubMed ID: 15798203)
1. Muscle-specific signaling mechanism that links actin dynamics to serum response factor.
Kuwahara K; Barrientos T; Pipes GC; Li S; Olson EN
Mol Cell Biol; 2005 Apr; 25(8):3173-81. PubMed ID: 15798203
[TBL] [Abstract][Full Text] [Related]
2. LMO7 mediates cell-specific activation of the Rho-myocardin-related transcription factor-serum response factor pathway and plays an important role in breast cancer cell migration.
Hu Q; Guo C; Li Y; Aronow BJ; Zhang J
Mol Cell Biol; 2011 Aug; 31(16):3223-40. PubMed ID: 21670154
[TBL] [Abstract][Full Text] [Related]
3. Striated muscle activator of Rho signaling is required for myotube survival but does not influence basal protein synthesis or degradation.
Wallace MA; Russell AP
Am J Physiol Cell Physiol; 2013 Aug; 305(4):C414-26. PubMed ID: 23720020
[TBL] [Abstract][Full Text] [Related]
4. Smooth muscle cell-specific transcription is regulated by nuclear localization of the myocardin-related transcription factors.
Hinson JS; Medlin MD; Lockman K; Taylor JM; Mack CP
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1170-80. PubMed ID: 16997888
[TBL] [Abstract][Full Text] [Related]
5. Myocardin-related transcription factors are required for skeletal muscle development.
Cenik BK; Liu N; Chen B; Bezprozvannaya S; Olson EN; Bassel-Duby R
Development; 2016 Aug; 143(15):2853-61. PubMed ID: 27385017
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors.
Lockman K; Hinson JS; Medlin MD; Morris D; Taylor JM; Mack CP
J Biol Chem; 2004 Oct; 279(41):42422-30. PubMed ID: 15292266
[TBL] [Abstract][Full Text] [Related]
7. Redox modification of nuclear actin by MICAL-2 regulates SRF signaling.
Lundquist MR; Storaska AJ; Liu TC; Larsen SD; Evans T; Neubig RR; Jaffrey SR
Cell; 2014 Jan; 156(3):563-76. PubMed ID: 24440334
[TBL] [Abstract][Full Text] [Related]
8. Actin dynamics control SRF activity by regulation of its coactivator MAL.
Miralles F; Posern G; Zaromytidou AI; Treisman R
Cell; 2003 May; 113(3):329-42. PubMed ID: 12732141
[TBL] [Abstract][Full Text] [Related]
9. Striated muscle activator of Rho signalling (STARS) is a PGC-1α/oestrogen-related receptor-α target gene and is upregulated in human skeletal muscle after endurance exercise.
Wallace MA; Hock MB; Hazen BC; Kralli A; Snow RJ; Russell AP
J Physiol; 2011 Apr; 589(Pt 8):2027-39. PubMed ID: 21486805
[TBL] [Abstract][Full Text] [Related]
10. Nuclear RhoA signaling regulates MRTF-dependent SMC-specific transcription.
Staus DP; Weise-Cross L; Mangum KD; Medlin MD; Mangiante L; Taylor JM; Mack CP
Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H379-90. PubMed ID: 24906914
[TBL] [Abstract][Full Text] [Related]
11. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor.
Liu HW; Halayko AJ; Fernandes DJ; Harmon GS; McCauley JA; Kocieniewski P; McConville J; Fu Y; Forsythe SM; Kogut P; Bellam S; Dowell M; Churchill J; Lesso H; Kassiri K; Mitchell RW; Hershenson MB; Camoretti-Mercado B; Solway J
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):39-47. PubMed ID: 12600823
[TBL] [Abstract][Full Text] [Related]
12. Reorganization of the actin cytoskeleton via transcriptional regulation of cytoskeletal/focal adhesion genes by myocardin-related transcription factors (MRTFs/MAL/MKLs).
Morita T; Mayanagi T; Sobue K
Exp Cell Res; 2007 Oct; 313(16):3432-45. PubMed ID: 17714703
[TBL] [Abstract][Full Text] [Related]
13. Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity.
Kuwahara K; Teg Pipes GC; McAnally J; Richardson JA; Hill JA; Bassel-Duby R; Olson EN
J Clin Invest; 2007 May; 117(5):1324-34. PubMed ID: 17415416
[TBL] [Abstract][Full Text] [Related]
14. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.
Cen B; Selvaraj A; Prywes R
J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164
[TBL] [Abstract][Full Text] [Related]
15. Regulation of STARS and its downstream targets suggest a novel pathway involved in human skeletal muscle hypertrophy and atrophy.
Lamon S; Wallace MA; Léger B; Russell AP
J Physiol; 2009 Apr; 587(Pt 8):1795-803. PubMed ID: 19255118
[TBL] [Abstract][Full Text] [Related]
16. Identification of the intermediate filament protein synemin/SYNM as a target of myocardin family coactivators.
Swärd K; Krawczyk KK; Morén B; Zhu B; Matic L; Holmberg J; Hedin U; Uvelius B; Stenkula K; Rippe C
Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1128-C1142. PubMed ID: 31461342
[TBL] [Abstract][Full Text] [Related]
17. Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation.
Selvaraj A; Prywes R
J Biol Chem; 2003 Oct; 278(43):41977-87. PubMed ID: 14565952
[TBL] [Abstract][Full Text] [Related]
18. Nuclear actin and myocardin-related transcription factors control disuse muscle atrophy through regulation of Srf activity.
Collard L; Herledan G; Pincini A; Guerci A; Randrianarison-Huetz V; Sotiropoulos A
J Cell Sci; 2014 Dec; 127(Pt 24):5157-63. PubMed ID: 25344251
[TBL] [Abstract][Full Text] [Related]
19. Myocardin-related transcription factors regulate the Cdk5/Pctaire1 kinase cascade to control neurite outgrowth, neuronal migration and brain development.
Mokalled MH; Johnson A; Kim Y; Oh J; Olson EN
Development; 2010 Jul; 137(14):2365-74. PubMed ID: 20534669
[TBL] [Abstract][Full Text] [Related]
20. STARS, a striated muscle activator of Rho signaling and serum response factor-dependent transcription.
Arai A; Spencer JA; Olson EN
J Biol Chem; 2002 Jul; 277(27):24453-9. PubMed ID: 11983702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
